title: AbbVie buys last available priority voucher for $350 million.
authors.forename: Chris
authors.initials: C
authors.lastname: Morrison
mesh_terms: D001709:Biotechnology / Q000191:economics* / Q000458:organization & administration*; D004345:Drug Industry / Q000191:economics* / Q000458:organization & administration*; D006801:Humans